Literature DB >> 9472047

Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.

H Daldrup1, D M Shames, M Wendland, Y Okuhata, T M Link, W Rosenau, Y Lu, R C Brasch.   

Abstract

BACKGROUND: The endothelial integrity of microvessels is disrupted in malignant tumors. Quantitative assays of tumor microvascular characteristics based on dynamic magnetic resonance imaging (MRI) were correlated with histopathologic grade in mammary soft tissue tumors.
MATERIALS AND METHODS: A spectrum of tumors, benign through highly malignant, was induced in 33 female rats by administration of N -ethyl-N -nitrosourea (ENU), a potent carcinogen. Dynamic contrast-enhanced MRI was performed using a small-molecular contrast medium [gadopentetate, MW = 0.5 kDa] and a macromolecular contrast medium [albumin-(Gd-DTPA)30, MW = 92 kDa] at an interval of 1-2 days. Permeability surface area product (PS), as estimated by the corresponding endothelial transfer coefficient (KPS), and fractional plasma volume (fPV) were calculated for each tumor and each contrast agent using a two-compartment bi-directional kinetic model. MRI microvascular characteristics were correlated with histopathologic tumor grade.
RESULTS: Tumor permeability to macromolecular contrast medium, characterized by KPS, showed a highly positive correlation with tumor grade (r 2 = 0.76, P < 10(-10)). KPS values were zero for all benign and some low-grade carcinomas, greater than zero in all other carcinomas, and increased in magnitude with higher tumor grade. A considerably smaller but significantly positive correlation was found between fPV and tumor grade using macromolecular contrast medium (r 2 = 0.25, P < 0.003). No correlation between KPS or fPV values and tumor grade was found using gadopentetate (r 2 = 0.01, P > 0.95 and r2 = 0.03, P > 0.15, respectively).
CONCLUSION: Quantitative tumor microvascular permeability assays generated with macromolecular MRI contrast medium correlate closely with histologic tumor grade. No significant correlation is found using small-molecular gadopentetate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472047     DOI: 10.1007/s002470050296

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  18 in total

1.  Accuracy of MRI in characterization of soft tissue tumors and tumor-like lesions. A prospective study in 548 patients.

Authors:  Jan L M A Gielen; Arthur M De Schepper; Filip Vanhoenacker; Paul M Parizel; Xiaoling L Wang; Raf Sciot; Joost Weyler
Journal:  Eur Radiol       Date:  2004-07-29       Impact factor: 5.315

2.  Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma.

Authors:  Cedric de Bazelaire; Nathalie Siauve; Laure Fournier; Frederique Frouin; Philippe Robert; Olivier Clement; Eric de Kerviler; Charles Andre Cuenod
Journal:  Eur Radiol       Date:  2005-08-23       Impact factor: 5.315

3.  Tumor vessel compression hinders perfusion of ultrasonographic contrast agents.

Authors:  Mirco Galiè; Mirko D'Onofrio; Maura Montani; Augusto Amici; Laura Calderan; Pasquina Marzola; Donatella Benati; Flavia Merigo; Cristina Marchini; Andrea Sbarbati
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

4.  Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma.

Authors:  Federico Boschi; Pasquina Marzola; Marco Sandri; Elena Nicolato; Mirco Galiè; Silvia Fiorini; Flavia Merigo; Vito Lorusso; Linda Chaabane; Andrea Sbarbati
Journal:  MAGMA       Date:  2008-03-04       Impact factor: 2.310

5.  Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).

Authors:  Clemens C Cyran; Barbara Sennino; Yanjun Fu; Victor Rogut; David M Shames; Bundit Chaopathomkul; Michael F Wendland; Donald M McDonald; Robert C Brasch; Hans-Juergen Raatschen
Journal:  Eur J Radiol       Date:  2011-09-01       Impact factor: 3.528

6.  Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors.

Authors:  Nail Bulakbasi; Murat Kocaoglu; Anar Farzaliyev; Cem Tayfun; Taner Ucoz; Ibrahim Somuncu
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

7.  Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI.

Authors:  M Meser Ali; Byunghee Yoo; Mark D Pagel
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

8.  Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.

Authors:  Clemens C Cyran; Barbara Sennino; Bundit Chaopathomkul; Yanjun Fu; Victor S Rogut; David M Shames; Michael F Wendland; Donald M McDonald; Robert C Brasch
Journal:  Eur Radiol       Date:  2008-07-30       Impact factor: 5.315

9.  MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft model.

Authors:  S O Aliu; L J Wilmes; M M Moasser; B C Hann; K-L Li; D Wang; N M Hylton
Journal:  J Magn Reson Imaging       Date:  2009-05       Impact factor: 4.813

Review 10.  Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Authors:  Zhuxian Zhou; Zheng-Rong Lu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.